NSEUpdates4d ago · 1 Sept 2026, 05:43 pm

Updates

Par Drugs and Chemicals Limited · PAR

✦ AI SummaryResults

Par Drugs and Chemicals Limited has informed the Exchange regarding 'Regulation 36 (1)(b)' and sent letters to members whose email addresses are not registered with the Company/Registrar & Share Transfer Agent/Depository Participants, providing the web-link to access the Annual Report for FY 2025-26 and the Notice convening the 27th Annual General Meeting of the Company.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Par Drugs And Chemicals Limited has informed the Exchange regarding 'Regulation 36 (1)(b)'.

Attachments (1)

📄

PAR_01092026174253_SignedUpdateReg36.pdf

pdf

Download →
View document text
("Par Registered Office : 815, Nilamber Triumph, Gotri-Vasna Road, Vadodara -390 007. Gujarat (INDIA). Ph. : +91-265-2991021 I 2991022 DRUGS AND CHEMICALS LIMITED Email: admin@pardrugs.com CIN No.: L24117GJ1999PLC035512 ---- - -------------------------------------- www.pardrugs.com PAR/CS/NSE/2026-27/ 17 To, Date: 01/09/2026 The Manager National Stock Exchange of India Limited Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra (E), Mumbai-400 051 Maharashtra Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") Ref: Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Symbol -PAR, ISIN: INE04LG01015 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform you that in compliance with the provisions of Regulation 36(1)(b) of the SEBI Listing Regulations, letters are being sent to those Members whose e-mail addresses are not registered with Company/Registrar & Share Transfer Agent/Depository Participants, providing the web-link, including the exact path, where complete details of the Annual Report is available & from where the Annual Report for FY 2025-26 and the Notice convening the 27th Annual General Meeting of the Company can be accessed. Further, Annual Report of Company for the Financial Year 2025-26 and Notice of the 27th AGM will be sent on September 3, 2026 through electronic mode to Members whose e-mail addresses are registered with the Depository Participant(s)/ MUFG lntime India Private Limited, RTA of the Company and whose name available in the register of members of the Company as on Friday, August 21, 2026. Accordingly, link of Annual Report as mentioned in the attached letter will be activated on September 3, 2026 by end of the day. A copy of the said letter is enclosed for your record. The above information is also available on the Company's website at www.pardrugs.com Please take the above on record. You are requested to kindly take note on your record. Yours Faithfully [ For PAR DRUGS AND CHEMICALS LIMITED: (Sanket B. Trivedi) Company Secretary & Compliance Officer Encl: As above Par Drugs And Chemicals Limited CIN: L24117GJ1999PLC035512 Registered office: 815, Nilamber Triumph, GotriVasna Road, Vadodara-390007, Gujarat, India Phone no.: 0265-2991021, 0278-2447013 Website: www.pardrugs.com Email: investors@pardrugs.com September 1, 2026 Dear Shareholders, Sub: Notice of 27th Annual General Meeting and Annual Report for the Financial Year 2025-26 We are pleased to inform you that the Twenty Seventh (27th) Annual General Meeting (“AGM”) of the Members of PAR DRUGS AND CHEMICALS LIMITED (“the Company”) will be held on Saturday, 26th Day of September, 2026 at 11:00 A.M. at Hotel Tara Suns, B/h Yash Complex, B/s Sonal Park, G.E.R.I. Road, Gotri, Vadodara -390021, Gujarat, India The Notice of the AGM along with the Annual Report for the Financial Year 2025-26 is being sent by electronic mode to Members whose e-mail IDs are registered with the Company / MUFG INTIME INDIA PRIVATE LIMITED, i.e. Registrar & Share Transfer Agent (“RTA”) of the Company or the Depository Participants (“DPs”). Based on the records available with the Company and/or its RTA and/or its DPs, your e-mail ID is not registered against your Demat Account / Folio No. Therefore, in accordance with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements)Regulations,2015,this letter is being sent to you informing that the Notice and Annual Report for Financial Year 2025-26 can be accessed through web-link, which is given below. Web-link of Annual Report: http://pardrugs.com/annual-reports.php Path for AnnualReport: www.pardrugs.com> Investors >Annual Reports &Returns> Year 2025-26 This letter is being sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or RTA of the Company as on the cut-off date as on August 21, 2026. In case you wish to register the e-mail id, please approach your respective DP in case you hold shares in electronic form or write to the RTA of the Company as given below MUFG INTIME INDIA PRIVATE LIMITED (Erstwhile LINK INTIME INDIA PRIVATE LIMITED) 5thFloor, 506 TO 508, Amarnath Business Centre – 1 ( ABC-1), Beside Gala Business Centre, Nr. St. Xavier's College Corner, Off C G Road, Ellisbridge, Ahmedabad - 380006. Tel : 079 - 2646 5179 Email : rnt.helpdesk@in.mpms.mufg.com , ahmedabad@in.mpms.mufg.com, investor.helpdesk@in.mpms.mufg.com Website: www.in.mpms.mufg.com / https://in.mpms.mufg.com/ All shareholder queries or service requests in electronic mode can be raised through the RTA's website, accessible at: https://web.in.mpms.mufg.com/helpdesk/Service_Request.html or +918108116767. Moreover, you are also requested to update your email address at the earliest either through your depository participants for electronic holding or send a communication to us / our RTA to facilitate the updation to continue receiving all important information & documents thereafter and encourage Green Initiative. Thanking you, Yoursfaithfully, For Par Drugs and Chemicals Limited Sd/- Mr. Sanket B. Trivedi Company Secretary & Compliance Officer FCS-13800